GIC’s Strategic Medline Sell‑Off: 25% Share Cut Sparks Market‑Rebalancing Insight
GIC’s recent Medline share sell‑off cuts its stake 25% yet keeps a core position—analyzing why the sovereign fund sees value in Medline’s tech‑enabled supply chain.
4 minutes to read

